Anika Therapeutics Inc
General ticker "ANIK" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $254.3M
Anika Therapeutics Inc does not follow the US Stock Market performance with the rate: -9.3%.
Estimated limits based on current volatility of 2.5%: low 15.83$, high 16.63$
Factors to consider:
- US accounted for 76.3% of revenue in the fiscal year ended 2022-12-31
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [16.85$, 29.51$]
- 2024-12-30 to 2025-12-30 estimated range: [15.91$, 28.20$]
Financial Metrics affecting the ANIK estimates:
- Negative: Non-GAAP EPS, $ of -5.65 <= 0.10
- Negative: Operating profit margin, % of -34.46 <= 1.03
- Positive: -0.96 < Investing cash flow per share, $ of -0.37
- Negative: Operating cash flow per share per price, % of -0.54 <= 2.35
- Negative: negative Net income
- Positive: Interest expense per share, $ of 0 <= 0
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term ANIK quotes
Long-term ANIK plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $147.79MM | $156.24MM | $166.66MM |
Operating Expenses | $145.18MM | $175.64MM | $254.30MM |
Operating Income | $2.62MM | $-19.40MM | $-87.64MM |
Non-Operating Income | $-0.19MM | $0.65MM | $2.31MM |
R&D Expense | $27.33MM | $28.18MM | $32.69MM |
Income(Loss) | $2.43MM | $-18.75MM | $-85.33MM |
Taxes | $-1.71MM | $-3.89MM | $-2.66MM |
Profit(Loss) | $4.13MM | $-14.86MM | $-82.67MM |
Stockholders Equity | $287.08MM | $285.56MM | $212.26MM |
Inventory | $36.01MM | $39.77MM | $46.39MM |
Assets | $347.54MM | $349.13MM | $270.63MM |
Operating Cash Flow | $8.40MM | $4.41MM | $-1.79MM |
Capital expenditure | $5.14MM | $7.49MM | $5.43MM |
Investing Cash Flow | $-3.12MM | $-7.49MM | $-5.43MM |
Financing Cash Flow | $-6.78MM | $-4.85MM | $-6.32MM |
Earnings Per Share* | $0.29 | $-1.02 | $-5.64 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.